Nothing Special   »   [go: up one dir, main page]

Europe PMC requires Javascript to function effectively.

Either your web browser doesn't support Javascript or it is currently turned off. In the latter case, please turn on Javascript support in your web browser and reload this page.

Logo of rscsdLink to Publisher's site
PMC full text:
Primary screening of compounds 4a–m on DYRK1A and DYRK1B
Entry An external file that holds a picture, illustration, etc.
Object name is d4md00537f-u1.jpg % inhibitiona,b at 1 μMIC50 for DYRK1Aa,b in nM
14aR5 = HR′′ = 10-OMeDYRK1A <5%nd
DYRK1B <5%
24bR5 = HR′′ = 9-OMeDYRK1A <5%nd
DYRK1B <5%
34cR5 = HR′′ = 8-OMeDYRK1A <5%nd
DYRK1B <5%
44dR5 = HR′′ = 7-OMeDYRK1A 23%nd
DYRK1B 7%
54eR5 = OMeR′′ = HDYRK1A 91%52
DYRK1B 68%
64fR5 = OMeR′′ = 10-OMeDYRK1A 28%nd
DYRK1B <5%
74gR5 = OMeR′′ = 9-OMeDYRK1A 25%nd
DYRK1B <5%
84hR5 = OMeR′′ = 8-OMeDYRK1A <5%nd
DYRK1B <5%
94iR5 = OHR′′ = HDYRK1A 98%105
DYRK1B 89%
104jR5 = OHR′′ = 9-OMeDYRK1A 99%116
DYRK 1B 93%
114kR5 = OHR′′ = 8-OMeDYRK1A 97%35
DYRK1B 78%
124lR5 = OHR′′ = 7-OMeDYRK1A 93%54
DYRK1B 78%
134mR5 = FR′′ = 8-OMeDYRK1A <5%nd
DYRK1B <5%
aCalculated after the measurement of residual kinase activity, using a functional, radiometric kinase assay.
bValues are the mean of two experiments with SD ≤ 20%.